Citigroup: JP Morgan lifts target as options traders sit cautious

Citigroup heads into the final days of October with a stock that gained 1.7% on the week yet shed 2.5% on Friday alone, a divergence that captures the push-pull running through the name right now.

Options positioning tells the clearest story of investor unease. The put/call ratio is running well above its recent average at 1.48, near the top of its 52-week range of 0.88 to 1.51, and roughly 0.8 standard deviations above its 20-day mean of 1.42. That persistent skew toward puts has been in place for most of October, a period during which the stock fell 6.2% on the month despite the week's partial recovery. The borrow market offers no supporting drama: availability is effectively unlimited, with over 1.6 billion shares available to lend and cost to borrow barely above 0.36%, near historic lows for the name. Short interest is also a non-story at just 1.2% of the free float, up 5.4% on the week in share terms but down 15% over the past month. There is no meaningful short base to unwind or squeeze here; the options skew is the primary expression of caution.

The Street's posture is broadly constructive but shows clear internal tension after the Q3 earnings miss in mid-October. JP Morgan's Vivek Juneja raised his price target to $148.50 from $147 as recently as October 30, maintaining an Overweight rating, the kind of incremental lift that signals continued conviction from a bellwether firm. Against that, Evercore ISI and RBC Capital both trimmed targets to $135 after the earnings print, while TD Cowen held its Buy rating with a $148 target. UBS stays Neutral at $139. The consensus sits at Buy with a mean target of $134.43, implying roughly 9.6% upside to Friday's close of $122.64. Valuation remains modest: the stock trades at just under 10 times trailing earnings and barely above book value at 1.01x, metrics that bulls argue leave room for re-rating as the restructuring progresses. The ORTEX EPS surprise factor score of 74 out of 100 suggests the company has a creditable beat record, but the Q3 print, which sent the stock down 7.3% on the day and a further 7.1% over the following week, reset expectations sharply.

The bull case centres on the 3Q26 results themselves: $23.8 billion in revenue, EPS of $2.85 up 53% year over year, ROTCE improving to 11.5%, and a 12% dividend increase to $0.67 per quarter alongside the $30 billion buyback programme. The Services franchise, generating $6.6 billion in revenue at a 31.2% ROTCE, remains the standout. Bears point to Corporate Lending revenue falling sequentially and year over year, DCM revenue dropping to $601 million from $732 million, and noninterest revenue deteriorating to negative $758 million. The macro risk cited in management commentary, including persistent inflation, policy uncertainty, and a possible 2027 recession, adds an external dimension that neither the bulls nor the valuation can fully dismiss.

ORTEX Alt Data adds two data points worth holding in mind, though neither has yet been measured to lead Citigroup's reported figures. FDIC call report data, published by the Federal Deposit Insurance Corporation, shows net loans and leases rising for nine consecutive quarters to $739.5 billion, and total deposits rising for six consecutive quarters to $1.55 trillion through June 2026. Both are streaks rather than leading signals: the datasets have not yet accumulated enough history to test for a lead relationship against reported income. Separately, 30-day-plus delinquencies across Citigroup's ABS trusts tracked at the 26th percentile relative to other trusts reporting the same month, a reading that is below the peer midpoint, though again the relationship to net charge-offs is untested. These data points colour the picture rather than sharpen any near-term read.

Among peers, Friday's broad bank selloff was notable: WFC fell 1.7% on the day and JPM dropped 1.9%, tracking Citigroup's decline closely. BAC fell 2.2%. European names had a rougher week: SAN lost 12.1% over five sessions and BBVA fell 5.3%, moves that reflect different rate and regulatory dynamics rather than a direct read-across to Citi.

The next scheduled earnings event is 14 January 2027, 75 days away. With two consecutive post-earnings declines of 4% and 7% on record, and options traders maintaining an elevated put bias well before that date, the tension between a cheap valuation and a cautious market posture is what will define the stock's next chapter.